Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2009 by National Cancer Institute (NCI).
Recruitment status was Recruiting

Study NCT00895739 Information provided by National Cancer Institute (NCI)

First Received on May 7, 2009. Last Updated on January 28, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Anemia
Anemia, Aplastic
Neoplasms

More general conditions related to this trial

Interventions listed in this trial

alemtuzumab
cyclosporine

Additional drug interventions recognized in this trial

Campath 1G
Cyclosporins

More general drug interventions related to this trial

Sponsors listed in this trial